Genetic dissection of the function of mammalian P-glycoproteins
- 1 June 1997
- journal article
- review article
- Published by Elsevier in Trends in Genetics
- Vol. 13 (6), 217-222
- https://doi.org/10.1016/s0168-9525(97)01112-8
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Transport of the anti-cancer drug doxorubicin across cytoplasmic membranes and membranes composed of phospholipids derived from Escherichia coli occurs via a similar mechanismBiochimica et Biophysica Acta (BBA) - Biomembranes, 1996
- ATP-binding cassette proteins as targets for drug discoveryTrends in Pharmacological Sciences, 1996
- What have we learnt thus far from mice with disrupted P-glycoprotein genes?European Journal Of Cancer, 1996
- P-glycoprotein—A mediator of multidrug resistance in tumour cellsEuropean Journal Of Cancer, 1996
- The catalytic cycle of P‐glycoproteinFEBS Letters, 1995
- The role of the MDR protein in altered drug translocation across tumor cell membranesBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1995
- The human MDR3 P‐glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic miceFEBS Letters, 1994
- Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver diseaseCell, 1993
- ABC Transporters: From Microorganisms to ManAnnual Review of Cell Biology, 1992
- Sequence of mdr3 cDNA encoding a human P-glycoproteinGene, 1988